News | May 8, 2026
A recent study by Tatyana Avilova, Economist at Secretariat has been selected by the Editor of JAMA Health Forum as an Editor’s Choice: Clinical Trial of 2025.
Dr. McLean is a world-renowned expert in the fields of biomechanics and wearable technology, presenting with over two decades of combined experience in a broad range of related areas and applications. He has applied these unique skills to advise and support high-profile large-scale clients in developing, integrating, and/or applying various technology solutions to better understand and enhance human health, wellness, and performance. In the litigation context, Dr. McLean applies this expertise to provide expert testimony in the areas of product liability, sports and fitness equipment, medical devices, and wearable technology intellectual property matters.
As a biomechanist, Dr. McLean has considerable expertise in 3-D motion capture, inertial measurement units, wearable sensors, medical imaging, cadaveric/mechanical testing, and computational modeling techniques, publishing extensively in these areas. He applies this combined state-of-the-art approach in litigation matters to uniquely advise clients on the root causes of bone, joint, and soft tissue trauma and injury in response to dynamic high impact loading scenarios. His related research has focused on anatomical injury causality in high-profile (athletic and military) populations, and resultant disease progressions across the lifespan. He has received multiple national grants, appointments, and awards for his extensive work in this area. Dr. McLean has also created novel biomechanical techniques, using combined wearable sensing and AI approaches, to evaluate user-product interactions in real-world application environments. These state-of-the-art techniques have supported targeted next-generation product design and associated product risk assessments for a broad range of sports and recreation equipment, outdoor apparel, medical device, and factory-based manufacturing clients.
Dr. McLean’s expertise in wearable technologies uniquely enables him to assist clients across all facets of technology ideation, development, optimization, and real-world integration. Specifically, he supports the wearable technology hardware, software and algorithm development processes through the design and application of appropriately scaled verification and validation techniques, in direct consideration of key demographic, activity, and environmental factors. His unique expertise in this area lies in the ability to distill the often large and unique data sets derived from these technologies into actionable metrics that can successfully characterize and enhance individual-specific health and performance outcomes.
Dr. McLean also advises clients in the military, clinical, pharmaceutical, and digital health spaces on identifying, testing, and applying fit-for purpose technology solutions to optimally inform key health, wellness, and performance outcomes in these unique populations. Moreover, he advises both technology development and technology integration clients on how to best navigate the growing data accuracy and reliability, legal, and regulatory challenges faced as wearable technologies transition from consumer products to more targeted medical monitoring devices. Dr. McLean additionally draws on this expertise in the litigation space to advise clients in intellectual property disputes, primarily involving patents and trade secrets.
Before joining Secretariat, Dr. McLean served as Principal in the Biomechanics practice for a large multinational engineering and scientific consulting firm. Prior to that, he was the Director of Innovation Research at Fitbit, where he played a key role in bringing multiple wearable products to market on a global scale. He was also a Professor at the University of Michigan, where he led multiple high-profile research initiatives geared towards human health and performance optimization and injury risk mitigation within naturalistic military, clinical, and sports environments. During his tenure at Michigan, Dr. McLean also gained considerable teaching experience in the fields of biomechanics, human anatomy, imaging, and computational modeling, both at undergraduate and graduate levels. He was initially a Project Staff Scientist and the Director and Sports Health and Orthopaedic Rehabilitation at the Cleveland Clinic, developing novel injury assessment and prevention techniques and simultaneously serving as a biomechanical consultant for Cleveland’s professional sporting teams.
Dr. McLean’s research and academic background have resulted in over 60 peer reviewed publications in national and international peer reviewed journals, over one hundred conference presentations, and multiple invited presentations, seminars and keynotes. He has also been awarded over $7 million in federal and private funding to support his research. He is a past chair and fellow of the American College of Sports Medicine Biomechanics group and a previous Executive Counsel member of the International Society of Biomechanics. He has served as an editorial board member on international journal publications in his field. Finally, Dr. McLean is also a past chair of the Consumer Technology Association’s Health, Fitness, and Wellness committee, which served to develop and implement actionable standards for wearable technology development, evaluation, and implementation.
A recent study by Tatyana Avilova, Economist at Secretariat has been selected by the Editor of JAMA Health Forum as an Editor’s Choice: Clinical Trial of 2025.
Secretariat Experts Recognized in Lexology’s 2026 Investigations Report
Ten of Secretariat experts have been recognized in the Lexology Index 2026 Investigations report, produced in partnership with Global Investigations Review. The guide highlights leading investigations lawyers, digital forensic specialists, and forensic accountants who are trusted to support the most demanding matters worldwide.
AI is rapidly reshaping how financial institutions in Latin America approach compliance, shifting from reactive monitoring to proactive financial crime detection. Advanced AI platforms specialized in crime detection enable banks to process vast datasets, identify anomalous behaviors, and map hidden relationships across accounts and jurisdictions. This is particularly relevant in a region characterized by complex cross-border flows, uneven regulatory enforcement, and significant exposure to illicit economies.